Answers are grounded in this paper and cite their sources.
Proprioceptive impairment is a common consequence of sports-related musculoskeletal injuries and is associated with altered neuromuscular control, impaired joint stability, delayed functional recovery, and an increased risk of reinjury. Conventional proprioceptive and sensorimotor assessments, including joint position sense testing, balance assessment, force-platform analysis, and isokinetic dynamometry, provide valuable clinical information, but they are often limited by laboratory dependence, intermittent measurement, cost, and reduced ecological validity. Wearable sensors, including inertial measurement units, pressure-sensing insoles, surface electromyography sensors, and sensor-integrated braces or smart textiles, provide portable quantitative measures of joint kinematics, postural control, gait, landing mechanics, and neuromuscular activation during functional tasks. This narrative review was informed by a structured, non-systematic literature search in PubMed, supplemented by targeted publisher searches and backward reference screening, updated through 31 August 2026, with an injury-focused PubMed update on 7 October 2026. English-language peer-reviewed studies and relevant reviews were prioritized, with direct evidence from sports-injury populations distinguished from indirect or transferable evidence from other populations. The review examines sensor modalities, their relationship to proprioceptive and broader sensorimotor outcomes, real-time biofeedback, home rehabilitation and remote monitoring, artificial intelligence-assisted analysis, and challenges in reliability, validity, and standardization. Current evidence supports technical feasibility and selected measurement and feedback applications, but many sensor-derived outcomes are influenced by pain, strength, fatigue, fear, attention, and compensatory strategies and should not be interpreted as direct measures of proprioceptive acuity. Evidence that wearable monitoring improves adherence, prevents reinjury, supports return-to-sport decisions, or enables clinically effective AI decision support remains limited. Clinical translation is further constrained by heterogeneous protocols, measurement error, limited external validation, small or selective datasets, privacy and usability concerns, and the absence of broadly accepted reference values. Future work should progress from analytical validation and reproducibility to prospective clinical validation, multicenter evaluation, and demonstration of athlete-relevant benefit.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: